Stockreport

Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock

Vor Biopharma Inc.  (VOR) 
PDF BOSTON, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Vor Biopharma Inc. (Nasdaq: VOR), a clinical-stage biotechnology company dedicated to transforming the treatment of autoimmun [Read more]